24 March 1999, 12:00PM (EST)
Panelists: Paul Coleman, Carl Cotman, Mark Smith, George Perry,
Mark Mattson (in absentia)
Audience: Luc Buee, Brian Cummings, Donna McPhie, June Kinoshita,
Ben Wolozin, Melissa, and a mysterious Dr. Jekyll from the other side of
the planet.
View the panelists' responses to some preliminary questions.
Submit a question or comment to the panelists.
This transcript has been edited to make the discussion more coherent
and to protect the innocent.
Paulcoleman says, "June, is Boston time noon yet?"
Junekinoshita says, "Welcome all. Let's wait a few minutes for stragglers."
Mcphie enters.
Smith says, "Where's Mattson?"
Junekinoshita says, "Hi Donna (or is that Rachael Neve in disguise?)"
Junekinoshita says, "I'm filling in for Mark, whose system keeps
crashing on iChat."
Mcphie says, "Hi June!"
Junekinoshita says, "Mattson sent me prepared remarks by e-mail.
If you have questions for him, I can transmit them by e-mail to Mark during
this discussion."
Cummings says, "George has a statement prepared. He cannot answer
until he unleashes his prepared statement."
Smith says, "Tell Mark to use the Java Client not i-Chat when he
logs selection...we crashed too."
Junekinoshita says, "I think we can begin."
Cummings says, "Yes, ichat is a memory hog. If you ar going to use
it, you must allocate more memory to browser or crash."
Smith says, "Tick tock tick tock."
Carlcotman says, "How would you like to start?"
Junekinoshita says, "Paul Coleman will be moderating."
Paulcoleman says, "So let's start with the statement George wanted
to make and take it from there."
Cummings says, "I'll start with coffee and a doughnut."
Perry says, "Opening Statement from George Perry and Mark A. Smith:
We think it is important to emphasize that this topic may not now be as
controversial as one might expect or as it was even a few months ago. In
fact, there appears to be a consensus that while much of the apoptotic machinery
is present, it may not necessarily be engaged in promoting cell death. Is
this apoptosis, avoidance of apoptosis or another phenomena? That is the
important question, i.e., what do we call this? Smith favors "abortosis",
i.e., abortive apoptosis, while Perry favors "avoidosis", i.e.,
avoidance of apoptosis. Whatever this shift, it is away from finality, and
there is no need to send sympathy cards to the neurons. More appropriate
may be "Best Wishes for a Happy Recovery!" The major question
is how do cells manage to survive at all in AD in the face of deleterious
changes occurring within neurons?"
Cummings nods solemnly.
{PRIVATE} Cummings tells Carlcotman "Sounds like they are trying
to steal your fire."
Paulcoleman says, "George's statement is interesting. But it is
clear that some of the genes usually associated with apoptosis are involved
in AD. The term apoptosis carries much baggage, but what counts is the cascade
of expression"
Smith says, "Yes, but solely with AD"
Carlcotman says, "We agree that in large part what neurons may be
doing is preventing terminal apoptosis. However, it would probably be more
structured to address some of the original issues on the table."
Paulcoleman says, "Go ahead Carl"
Perry says, "Do you mean the questions [that were sent around in
advance]?"
Carlcotman says, "Well, Re: the first question regarding what the
most compelling evidence for apoptosis in AD is. We feel that the most compelling
issue is 1) the presence of morphologically apoptotic nuclei; 2) the absence
of a large degree of necrosis; 3) the fact that neuronal loss exceeds NFT
formation in at least some areas; and 4) the fact that apoptotic mechanisms
appear to affect synapses and neurites."
Smith says, "Regarding point 1. This is seldom ever seen ...true?"
Perry says, "1) There are very few apoptotic nuclei in AD and 3)
NFT may be a protective response"
Junekinoshita says, "Here are Mark's comments regarding the evidence
for apoptosis. I think it's useful for people to see them. "
Junekinoshita says, "Mark makes 4 points: 1) "patchy"
distribution of degenerating neurons within affected brain regions."
Paulcoleman says, "Can we agree that PCD [programmed cell death]
can be used here to avoid the baggage of apoptosis?"
Lucbuee enters.
Smith says, "Makes no difference to me."
Perry says, "I am not sure that these terms are equivalent. Predominantly
because apoptosis does have baggage."
Carlcotman says, "No, PCD and apoptosis cannot be equated."
Paulcoleman says, "The intent was not to equate them, but to adopt
a more general term"
Carlcotman says, "PCD is not a more general term."
Cummings says, "Does this avoid the problem? Are Perry and Smith
saying that the neuronal loss in AD is not due to apoptosis or PCD, or that
only some of it is?"
Smith says, "Cells do not predominantly die by apoptosis"
Carlcotman says, "Then how do we account for up to 90% neuronal
loss?"
Smith says, "Cell death!"
Paulcoleman says, "The proposal of NFT as protective has analogy
to the inclusions in HD, which some now think are protective"
Smith says, "How this occurs is unlikely through apoptosis, or at
least apoptosis as defined."
Carlcotman says, "How do you define apoptosis?"
Smith says, "Perry is answering."
Perry says, "Apoptosis is a series of changes that in neurons involves
mitochondrial disruption in nuclear condensation and eventually phagocytosis
of the remaining cell body by macrophages. This is seldom seen in AD."
Carlcotman says, "Yes, it's seldom seen because few neurons are
in active apoptosis at any give time, this is consistent with the progression
of cell loss in the disease."
Perry says, "Obviously, cells do die in AD. But it takes time."
Junekinoshita says, "Can I submit Mark's response to Perry's point?"
Smith says, "Yes"
Carlcotman says, "We have suggested that neurons as nondividing
cells have a series of apoptotic checkpoints that compensate for neuronal
injury and prolong entry into terminal apoptosis. Therefore, while few actively
apoptotic neuronas are present, many TUNEL positive neurons can be present."
Carlcotman says, "In support of this negative regulatory factors
are expressed in injured neurons in AD (e.g., bcl-2, gad45, p16)."
Junekinoshita says, "Mattson says: That AD is a slow, chronic neurodegenerative
process strongly favors apoptotic (vs. necrotic) mode of neuronal death.
Numerous studies (in cell culture and in vivo) have shown that lower intensity,
longer duration insults will induce neuronal apoptosis, whereas higher intensity
insults will induce necrosis" (more to come)."
Junekinoshita says, "[Continuing to transmit Mattson's comments]
"Examples include titration of exposure to glutamate, iron and A beta
in culture, and the gradient of neuonal injury in focal ischemia - necrosis
in the ischemic core and apoptosis in the penumbra."
Perry says, "Yes June. But, is ten years the usual time course for
culture studies? When one is talking about long term changes the time frame
is usually days in culture. Instead in AD, only a few neurons are ever actually
dying over any time frame. Therefore, what is in fact changing is something
that takes years to develop or instead is a process that is avoided -- avoidosis."
Smith says, "But [getting back to Carl's point,] TUNEL is late. Are
[the neurons] capable of stopping [apoptosis] at this point?"
Perry says, "TUNEL positivity is not specific for the nuclear changes
of apoptosis."
Smith says, "Response to Carl......as with other things, the question
is whether these are specific for apoptosis."
Carlcotman says, "Apoptotic bodies, caspase activation, the appearance
of caspase-dependent cleavage products are all clearly apoptotic changes."
Jjohnso2 enters.
Smith says, "Yes, but these are the rarely seen events...the other
events are widespread and usually equated to apoptosis."
Mattson enters.
Carlcotman says, "What other events?"
Mattson leaves [system crash?]
Smith says, "bcl, bax etc"
Carlcotman says, "We don't equate bcl-2 with terminal apoptosis,
we say that these pathways regulate apoptosis and may delay death commitment."
Smith says, "I know you do not, but others have. Related to this,
how long would you expect a TUNEL positive cell to survive in vivo?"
Perry says, "Regarding apoptosis or other forms of cell death in
culture: there are ample suggestions that this is very situation-dependent
and predominantly influenced by the artifacts intrinsic to cells maintained
outside of their natural environment."
Paulcoleman says, "In addition to bcl-2 there are a number of cellular
defenses mounted in AD. Why are they not operating as effectively in vitro?"
Jc6 enters.
Smith says, "Perhaps they are!"
Perry says, "But they may very well be doing so. The neurons are
alive!"
Carlcotman says, "Perhaps a very long time. This is the point: There
are DNA and other cellular repair mechanisms that are active as a part of
an apoptotic checkpoint in AD neurons, and therefore few cells apoptose
at any given time."
Smith says, "Is this apoptosis!"
Carlcotman says, "The problem may be that the cell death inducers
(AGEs, oxidative stress, A beta) don't go away, and so neurons may not ever
be able to completely recover and exhibit prolonged damage."
Perry says, "But they do! That's the point! These neurons are majorily
damaged and they are alive. The question is how they do it."
Smith says, "Rar Rar!"
Cummings says, "Apoptotic nuclei (by morphological criteria) ARE
seen in AD, even if they are rare. Thus, avoidosis isn't really accurate.
If apoptosis occurred at a very slow rate, this would account for two things,
(1) seeing only a few apoptotic nuclei in an AD brain sections, and (2)
the large loss of neurons over a ten year period."
Smith says, "Great, then what about ABORTOSIS."
Cummings says, "Mark Smith, clarify what you mean and maybe I can
comment."
Smith says, "Abortosis = abortive apoptosis...in other words perhaps
initiated in large numbers of cells but then aborted in all/most."
Perry says, "Yes, the neurons that actually die may be dying by
apoptosis. But all the neurons, ALL the neurons, show apoptotic markers.
Therefore, apoptotic markers do not mean, and cannot mean, that the pathway
classically defined as apoptosis or most concepts of programmed cell death
are activated because they take at most days."
Junekinoshita says, "Well, maybe we're just ignorant about actual
apoptotic processes in living human brains."
Perry says, "June, I think you may be right."
Carlcotman says, "All neurons do not show apoptotic markers."
Carlcotman says, "Why do you say that all neurons show apoptotic
markers?"
Perry says, "Did you not show that all neurons show TUNEL positivity?"
Carlcotman says, "No"
Paulcoleman says, "The fact that all neurons do not show current
apoptotic markers need not mean that at some time they do not go through
this state."
Perry says, "Which vulnerable neurons do not show TUNEL positivity?
We also performed end labeling and found that all vulnerable neurons as
well as some other cells showed DNA fragmentation. There was little difference
between cells of the same population. This is the same pattern seen for
oxidative damage."
Smith says, "Paul...but most do show "apoptotic markers"
the question is whether they mean apoptosis."
Paulcoleman says, "The fact that few cells show criteria for apoptosis
suggests that they are in the state indicated by these criteria for only
a short time. But what is leading up to this state?"
Junekinoshita says, "That's the key question. If cells are avoiding
apoptosis, what is stressing them out in the first place?"
Carlcotman says, "Probably what leads up to the state is a series
of accumulating damage/inducers in which the neuron is being driven towards
apoptosis but attempting to compensate and repair the damage."
Smith says, "What causes...take your pick of your favorite inducer....ox
stress or cell cycle is mine...surprising"
Junekinoshita says, "Re: stressors, are we all under increased ox
stress with age and just some individuals are more vulnerable to its effects?"
Junekinoshita says, "Or is it that some or us are generating more
ox radicals?"
Cummings says, "Can we agree on Mark's term abortosis, which would
imply that some cells do in fact undergo apoptosis while others manage to
avoid it. This sounds like a process that Cotman and Anderson have being
suggesting for several years."
Smith says, "Yes, but without the funky name!"
Smith grins evilly.
Perry says, "I still like "avoidosis"."
Junekinoshita says, "Sounds like a case of terminal procrastination."
Smith says, "Perry is very 'old-school'"
Carlcotman says, "We call it an apoptosis checkpoint cascade."
Paulcoleman says, "I certainly would like to see some agreement
that would avoid semantics and get to mechanisms."
Carlcotman says, "ok"
Carlcotman says, "TUNEL cannot be equated with either apoptotic
or necrotic cell death."
Cummings laughs hysterically.
Perry says, "Carl, but isn't that what you published in several
articles????? Can you clarify this?"
Carlcotman says, "Yes. As one example you could argue that, in parallel
with the cell cycle in dividing cells, there are a series of compensatory
mechanisms (bcl-2, gad45, p16...) that repair damage and prevent commitment
to terminal apoptosis"
Perry says, "But Carl, back to the question of TUNEL."
Cummings says, "Carl, why are so many cells TUNEL positive? They
are not all apoptotic?"
Smith says, "Go Cummings!"
Carlcotman says, "Absolutely not. Only TUNEL-positive cells with
apoptotic morphologies (condensed chromatin/apoptotic bodies) are apoptotic,
the rest are merely damaged. ALso TUNEL labeling is a function of disease
progression. Even early on there is dramatic labeling before cell loss."
Perry says, "Is that what you said in your earlier papers?"
Carlcotman says, "Yes"
Carlcotman says, "Cummings - get back to work!"
Cummings says, "So ApopTag is a lousy name for a labeling kit !"
Carlcotman says, "YES!!!"
Cummings bows gracefully.
Perry says, "Then why did you use it? And how often are nuclear
morphology of apoptosis seen in AD? And didn't Lassmann as well as Lucassen
find that there was no increase in this morphology in AD?"
Carlcotman says, "Because it is an indicator of damage, isn't that
of interest in AD?"
Carlcotman says, "I'm not sure what other people don't see as much
morphology as we do, all I can say is that we have exceptional tissue quality.
Short-postmortem, and excellent fixation."
Perry says, "But, that is not the story I remember from the earliest
papers. Even to this day, I have manuscripts on my desk for review that
cite your work suggesting that apoptosis involves all the neurons in AD.
How did so many wise authors make this error?"
Carlcotman says, "That is never what we said in our manuscripts."
Cummings says, "George, classic example of people mis-citing others
work."
Cummings says, "Anderson and Cotman argued DNA damage back in the
initial papers."
Carlcotman says, "In fact, we were the first to point out that this
didn't make sense (anderson j neurosci 1996)"
Paulcoleman says, "Carl, your last statement suggests you send some
sections to others from your material."
Paulcoleman says, "Since you suggest that your ability to see morphology
reflects short PMD and fixation, why not send some material to others to
see if they replicate?"
Carlcotman says, "Absolutely we would be pleased to send sections,
tissue, etc"
Smith says, "What about work with Su?"
Carlcotman says, "The Neuroreport paper?"
Smith says, "Among others."
{PRIVATE} Cummings tells Smith "Su is one of us, he wouldn't say
anything we wouldn't agree with :)"
Carlcotman says, "That was the only one before the Anderson paper"
Junekinoshita says, "What I want to know is this: Are neurons going
down an apoptotic pathway as a response to some nonspecific insults (i.e.
ox stress, A beta toxicity, etc.), or is the apoptosis being triggered by
a specific aberrant molecule?"
Smith says, "Why is A beta or ox stress non-specific....It is likely
as specific as anything!"
Carlcotman says, "We would say that it's striking that almost every
risk factor in AD is proapoptotic - A beta, oxidative injury, genetic mutations,
excitotoxicity etc..."
Paulcoleman says, "So, in answer to June, would you suggest Carl
that there are many paths to apoptotic cell death?"
Junekinoshita says, "Reminds me of an Agatha Christie mystery (Death
on the Nile?) in which everyone has a motive and it turns out everyone is
the murderer."
Cummings smiles at Junekinoshita.
Carlcotman says, "Paul- yes we would suggest that there are many
pathways, from ic mediated to receptor mediated."
Perry says, "On the issue of the response to an insult, I think
that apoptotic changes are specifically related to problems of energy metabolism
involving mitochondria and necessary compensatory changes to maintain life."
{PRIVATE} Cummings tells Carlcotman "Also indicate that paraffin
poses problem....and remind them of autolysis curve"
Perry says, "Maybe, Carl, we are agreeing on what's really happening
in AD. The changes we and you have documented are not a path to rapid death.
Can we agree on that?"
Carlcotman says, "We say yes to Perry - I think we do agree that
cell death is not necessarily rapid, but reflects a struggle to compensate
for injury."
Carlcotman says, "Perry's comment about responses to insult is interesting
because Mark's group and ours have both argued that neuronal processes can
mobilize apoptotic pathways and degenerate via a type of local apoptosis."
Smith says, "What is local apoptosis!"
Smith says, "Is that like cell-free apoptosis?"
Carlcotman says, "We have called it neuritic apoptosis. Mark calls
it synapoptosis. It is defined by the activation of caspases, phosphotidylserine
inversion, and presence of caspase cleavage products in neuronal processes
selectively exposed to insult or in synaptosomal preps (Ivins neurobio disease
1998)"
Perry says, "Yes, I would imagine that synapses would be particularly
affected since they rely totally on microtubules for maintenance. Calcium
homeostasis is the major control mechanism of microtubules. The synaptophysin
changes of AD may reflect a loss of synaptic vesicle transport as suggested
by Terry rather than frank synapse loss."
Junekinoshita says, "Let me introduce a question that, perhaps,
also addresses the issue of why neurons appear to be heading down an apoptotic
pathway in AD: Are we seeing a recapitulation of a developmental process?
If so, why is it happening?"
Carlcotman says, "Perhaps some neurons do in fact recapitulate developmental
events, but in development, the inducers are more likely to be substrate
or trophic factor deficiencies, whereas in AD the inducers are things like
A beta and other insults, and may may give rise to a more complicated set
of molecular pathways"
Smith says, "Why not the same as development which then, in old
brain, leads to A beta and other insults? The chronology is far from clear."
Carlcotman says, "Well, there is no oxidative stress, AGEs or A beta
in development."
Perry says, "I am not sure the changes of AD that appear to be related
to development are really the same because in development, neurons die rapidly
following entry into apoptosis and do not linger for years. In AD, these
changes may instead reflect protective responses rather than a frank developmental
one. But of course neurons in late age are likely to rely on mechanisms
of earlier life."
Carlcotman says, "We agree with Perry."
Smith says, "Wow"
Perry says, "Are we sure there is no oxidative stress or amyloid
beta earlier in life?"
Carlcotman says, "The other issue is that as Davies and others have
suggested, some of the cell cycle mechanisms, which may contribute to an
apoptosis checkpoint, if prolonged could lead to NFT formation."
Carlcotman says, "In Down syndrome tissue the earliest A beta is
seen at about 16 years, not before. And that's with APP acceleration."
Junekinoshita says, "Allow me to post Mark's response to an earlier
question re: time course: "We do not know the time course of the cell
death process in individual neurons in AD. Moreover, an individual neuron
may be slowly and progressively compromised in terms of its function and
homeostasis for a very long period (e.g. months to year) before it initiates
the apoptotic process which then leads to more rapid cell death. I agree
it is likely that neurons are stressed for a long time before they die.
I also agree it's likely that neurons respond to stress by activating mechanisms
designed to prevent cell death. I strongly disagree that this argues against
an apoptotic mechanism of neuronal death in AD. I surmise that apoptosis
is the most likely mode of cell death in cells that succumb after a long
battle against the forces of evil at work in the AD brain."
Perry says, "Carl, I think you as well as Peter Davies may be correct."
Smith says, "Most cells with altered cell cycle elements do not
contain NFT, so this may be a reasonable speculation."
Carlcotman says, "Yea Mark."
Smith says, "Smith or Mattson?"
Carlcotman says, "Mattson. Sorry :)"
Carlcotman says, "It seems like there is some debate still on when
and where cell cycle proteins are, this is probably also a factor of disease
state and brain region"
Perry says, "My comments are not whether cells die by apoptosis.
It is whether all the neurons that show apoptotic markers have entered an
apoptotic pathway. June, we cannot underestimate the importance of this
distinction. It is the difference of sending a wreath or a get well card."
Smith says, "The cell cycle stuff certainly needs further work..it's
interesting."
Carlcotman says, "We agree, this is the most important issue. However,
again, all neurons with TUNEL labeling have not entered an apoptotic pathway."
Smith says, "TUNEL IS AN END EVENT SURELY."
Carlcotman says, "We were commenting on the extended Mattson response,
however, we think we also have some agreement with Smith and perry"
Perry says, "But most studies on apoptosis suggest DNA fragmentation
is one of the last events. Of course, this would not be the case if fragmentation
was the result of oxidative events only."
Carlcotman says, "ABsolutely not - TUNEL does not equal double strand
breaks. Terminal transferase can also label single strand breaks/nicks and
even transcribing cells or cells in DNA repair"
Smith says, "ie., oxidative strand breaks."
Carlcotman says, "Yes."
Perry says, "Okay. I agree."
Smith says, "So, without TUNEL where is the apoptosis story?"
Carlcotman says, "Again, it's the MORPHOLOGY."
Smith says, "But what morphology...I know you see it but others
do not...therefore rare rare rare."
Carlcotman says, "Of course, there is also a growing literature
on the caspase story in AD (e.g. Greg Cole's work)"
Smith says, "We also have great caspase data but do not equate to
apoptosis."
Perry says, "But Carl, how many papers have documented substantial
nuclear and other specific changes of apoptosis in a substantial number
of neurons in AD?"
Smith says, "He's tough."
Cummings says, "Yea, he's tough, but I think we are turning him."
Cummings listens to Smith.
Smith says, "He'll be back."
Carlcotman says, "In fact, we agree that the number of actively
apoptotic events in the AD brain should be very small. You have estimated
that this would equate to about 1/4000 neurons with active apoptosis. In
fact, based on the number of neurons in 50 micron sections of STS, Perry
and Smiths predictions of the number of apoptotic cells would translate
to roughly 25 actively (morphologically) apoptotic neurons per 50 micron
section - and this is about what we see at any given time in any given section."
Perry says, "Has that figure been confirmed by other laboratories?"
Carlcotman says, "Many from our group, Athena neurosciences have
also seen it, and at Case Western."
Smith says, "Who at CWRU?"
Carlcotman says, "Don't think it's been published. We are looking
for the Case Reference - Herrup?"
Carlcotman says, "We think the real point here is that there is
a need for much more precise quantification based on disease progression
and brain area."
Smith says, "Herrup did some confirmatory work on cell cycle...not
on apoptosis..if its the J. Neurosci paper."
Smith says, "Q? Do we think this is therapeutically relevant?"
Carlcotman says, "Also - the Stadelmann paper (J Neuropath?) comments
on apoptotic morphologies in AD in a few cells."
Perry says, "Or is the point the need for a precise definition of
what is being studied?"
Cummings says, "Therapeutically relevant to block apoptosis, probably
not, but to help with DNA repair, maybe yes."
Carlcotman says, "Yes we think its therapeutically relevant. The
vast majority of neuronal loss in AD occurs in the absence of NFT formation
(Gomez-Isla and Hyman) and in the absence of necrotic morphology. Therefore,
taken with the neuritic apoptosis issue, this is clearly an important target
for early intervention."
Smith says, "Agree, with DNA comment, because cause irrelevant,
only target."
Cummings says, "Carl, what target, blocking apoptosis or aiding
in cell stabilization, DNA repair?"
Perry says, "Yes, and note Lassmann (Stadelmann first author) agreed
with the conclusions of our recent letter in Science and was an author of
that letter."
Carlcotman says, "Debating the Lassman paper involves far more subtle
issues than we can get into here and stay on target."
Carlcotman says, "It's clear that apoptosis reflects a series of
thresholds to injury. The goal would be to raise the threshold for apoptosis
and allow the cell to recover."
Perry says, "Most neurons that die in AD do not have NFT. We also
found reported this several years ago before Hyman."
Carlcotman says, "We agree."
Perry says, "Further, in recent studies, we found that oxidative
damage was reduced between 50-60% by the presence of an NFT in a neuron."
Carlcotman says, "We don't argue that NFTs could be protective against
some types of insult, however, these neurons are clearly not healthy and
have impaired transport, trafficking etc."
Smith says, "OK, but they are not dead."
Carlcotman says, "No, most NFTs, until they are extracellular, are
not dead."
Junekinoshita says, "What about the tau mutation diseases?"
Smith says, "What about the French revolution?"
Smith laughs hysterically.
{PRIVATE} Cummings tells Smith "That was great !"
Junekinoshita pouts
Junekinoshita says, "I mean, wouldn't they argue against a protective
role for NFTs?"
Perry says, "Yes. They are not healthy or happy. But in studies
of biopsy specimens we have found that neurons with NFT actually have a
more normal organization than those without NFT."
Carlcotman says, "The story there really isn't clear yet. We have
a paper in press on the presence of TUNEL, BAX, and caspase 3 activation
in Frontal temporal dementia (related to tau mutations)"
Paulcoleman says, "So does this aspect of the discussion suggest
that neurons sacrifice some functions to maintain others?"
Smith says, "No....much as mutations in APP do not argue for A beta...but
that's another discussion."
Perry says, "Paul, I think you have the essence of my argument here.
The neurons sacrifice function for life."
Carlcotman says, "To Paul: perhaps neurons may be making a series
of compromises"
{PRIVATE} Cummings tells Smith "Blasphemer!"
Paulcoleman says, "George I like the way you put that."
Smith says, "We all agree...lets hug"
Junekinoshita says, "But why would the rest of the body let a neuron
get away with that --being a no-good freeloader, consuming resources while
doing nothing?"
Junekinoshita hugs back
Smith says, "Because it wants the neuron to live."
Carlcotman says, "live and fight another day."
Smith says, "I prefer a manky arm to no arm at all."
Perry says, "Because the alternative is even worse. How can the
brain function without neurons? I think the program that the neurons use
in AD are those that are successful compensatory changes of acute problems."
Junekinoshita says, "We're beyond the end of the hour. Any final
remarks?"
Carlcotman says, "So, Paul, have we reached a resolution, at least
in terms of clarifying the issues?"
Junekinoshita says, "I'll be posting a transcript, so you all can
respond in greater detail later on."
Paulcoleman says, "It appears time is drawing to a close. I would
like to comment that I think much of the discussion would be clarified if
we had a clearer picture of the molecular cascades involved."
Smith says, "Paul...bang on."
Carlcotman says, "One of the real values of a hypothesis is that
it can be tested, and indeed the apoptosis hypothesis has been a productive
one and continues to have many directions to pursue."
Smith says, "Great....some agreement but enough differences to make
life bearable"
Carlcotman says, "Great line Smith!"
Cummings nods solemnly.
Perry says, "In AD, the choices available for the neurons is death
or zombie status. In early life, when the fundamental abnormality may resolve
itself, this zombie status may have a protective role. In AD it may not
make that much of a difference in brain function."
Carlcotman says, "Bye all, thanks for the debate."
Smith says, "Thanks fore the memories!"
Cummings waves goodbye
Paulcoleman says, "Great to chat with you all"
Smith says, "Who won?"
Smith says, "Perry...let's wait them out."
Perry says, "Bye!"
Paulcoleman says, "It's how you play the game."
Smith says, "What...you turncoat."
Carlcotman leaves.
Smith says, "One down."
Paulcoleman says, "Another..."
Smith says, "Ok.....gone."
Junekinoshita says, "Bye! Thanks to all of you for participating
in this very lively discussion!"
Perry says, "Thank you June."
Smith leaves.
Dr_jekyl leaves.
Paulaleigh leaves.
Cummings leaves.
Perry leaves.
Melissa2 leaves.
End of transcript...but not end of discussion!!
View the panelists' responses to some preliminary questions.
Submit a question or comment
to the panelists.
|